6.26.24 CatSci Ltd, an innovation partner for medicines development, has acquired Reach Separations, a specialist chromatography provider for the analysis and purification of therapeutics. The acquisition was supported by Keensight Capital, a private equity manager dedicated to pan-European Growth Buyout investments.
CatSci News Full Screen View
Market Place
Share